The market faces challenges such as high costs of sophisticated devices and rural preference for traditional methods, but ...

Discover why Regeneron Pharmaceuticals, Inc.'s Q3 earnings impress, fueled by Dupixent growth and a robust pipeline. Click ...

Regeneron is planning to re-apply to the FDA with a new pre-filled syringe manufacturing filler in January 2026.

Opinion - In South Africa, two people can live with the same chronic condition yet face vastly different realities.

In Nigeria, a silent health crisis is unfolding—diabetes, once thought to be an adult disease, is increasingly affecting ...

As local advocates work to create a syringe exchange program in Evansville, the framework for the whole system is up in the ...

Learn about the new California laws addressing pet rescue, transgender ID changes, and sterile syringes for disease ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. On one wall of endocrinologist Kevan Herold’s ...

Many people with diabetes prefer an insulin pump to insulin injections. Here's how to know if it's right for you.

The difference between type 1 and type 2 diabetes is that people with type 2 have a wider variety of treatment options.